Skip to main content
. 2019 Oct 17;9:14907. doi: 10.1038/s41598-019-51445-w

Figure 4.

Figure 4

(A) In vitro specificity of [111In]In-DOTA-HE3-ZCAIX:2 binding to renal cell carcinoma SK-RC-52 cell line. In blocking group, receptors were pre-saturated by 100-fold excess of nonlabeled HE3-ZCAIX:2. (B) Internalization of [111In]In-DOTA-HE3-ZCAIX:2 by renal cell carcinoma SK-RC-52 cells during continuous incubation. Cells were incubated with conjugate (10 nM) at 37 °C. Data are normalized to the highest cell-bound activity and presented as mean values from 3 cell dishes and SD. Error bars might be not seen because they are smaller than symbols.